This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Merck KGaA.UK's NICE Recommends Use of Erbitux for Metastatic Colorectal Cancer Patients. Media Release: 1 Jun 2009. Available from: URL: http://www.merck.de
Rights and permissions
About this article
Cite this article
Cetuximab gets the nod from NICE. Pharmacoecon. Outcomes News 580, 10 (2009). https://doi.org/10.2165/00151234-200905800-00026
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905800-00026